Skip to Main Content

FDA Clearance Received for Dexcom G7

December 9, 2022
CGM Technology and Digital Health
Article / Publication

Dexcom G7 is now cleared in the U.S. for people with all Types of diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution. The next-generation real-time continuous glucose monitoring system demonstrates comparable accuracy to previous versions while offering a smaller sensor and enhanced ease-of-use features.

Learn More
Share: